Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen M Fernandez-Martos

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Brain and Behavior|December 22, 2021
The potential benefit of leptin therapy against amyotrophic lateral sclerosis (ALS)Agueda Ferrer-Donato, Ana Contreras, Paloma Fernandez, et al.
International Journal of Molecular Sciences|October 13, 2021
Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS)Agueda Ferrer-Donato, Ana Contreras, Laura M Frago, et al.
Journal of Neuropathology and Experimental Neurology|June 25, 2024
Alterations to metabolic hormones in amyotrophic lateral sclerosis and frontotemporal dementia postmortem human tissueRachel A K Atkinson, Jessica M Collins, Jemeen Sreedharan, et al.
Animals : an Open Access Journal From MDPI|December 10, 2020
Methodology Aspects of Colony Maintain for a Murine Model of Amyotrophic Lateral Sclerosis (ALS) TDP-43 ProteinopathyCésar Álvaro-Alonso, Águeda Ferrer-Donato, Elizabeth Fernández-Torres, et al.
Scientific Reports|June 7, 2017
Environmental novelty exacerbates stress hormones and Aβ pathology in an Alzheimer's modelKimberley E Stuart, Anna E King, Carmen M Fernandez-Martos, et al.
Neurobiology of Aging|September 8, 2015
Neurofilament light gene deletion exacerbates amyloid, dystrophic neurite, and synaptic pathology in the APP/PS1 transgenic model of Alzheimer's diseaseCarmen M Fernandez-Martos, Anna E King, Rachel A K Atkinson, et al.
Acta Neuropathologica Communications|September 27, 2015
C9ORF72 expression and cellular localization over mouse developmentRachel A K Atkinson, Carmen M Fernandez-Martos, Julie D Atkin, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer's diseaseCarmen M Fernandez-Martos, Rachel A K Atkinson, Meng I Chuah, et al.
Acta Neuropathologica Communications|January 6, 2016
Erratum: C9ORF72 expression and cellular localization over mouse developmentRachel A K Atkinson, Carmen M Fernandez-Martos, Julie D Atkin, et al.
The Journal of Comparative Neurology|December 18, 2016
Mid-life environmental enrichment increases synaptic density in CA1 in a mouse model of Aβ-associated pathology and positively influences synaptic and cognitive health in healthy ageingKimberley E Stuart, Anna E King, Carmen M Fernandez-Martos, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Brain and Behavior|December 22, 2021
The potential benefit of leptin therapy against amyotrophic lateral sclerosis (ALS)Agueda Ferrer-Donato, Ana Contreras, Paloma Fernandez, et al.
International Journal of Molecular Sciences|October 13, 2021
Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS)Agueda Ferrer-Donato, Ana Contreras, Laura M Frago, et al.
Journal of Neuropathology and Experimental Neurology|June 25, 2024
Alterations to metabolic hormones in amyotrophic lateral sclerosis and frontotemporal dementia postmortem human tissueRachel A K Atkinson, Jessica M Collins, Jemeen Sreedharan, et al.
Animals : an Open Access Journal From MDPI|December 10, 2020
Methodology Aspects of Colony Maintain for a Murine Model of Amyotrophic Lateral Sclerosis (ALS) TDP-43 ProteinopathyCésar Álvaro-Alonso, Águeda Ferrer-Donato, Elizabeth Fernández-Torres, et al.
Scientific Reports|June 7, 2017
Environmental novelty exacerbates stress hormones and Aβ pathology in an Alzheimer's modelKimberley E Stuart, Anna E King, Carmen M Fernandez-Martos, et al.
Neurobiology of Aging|September 8, 2015
Neurofilament light gene deletion exacerbates amyloid, dystrophic neurite, and synaptic pathology in the APP/PS1 transgenic model of Alzheimer's diseaseCarmen M Fernandez-Martos, Anna E King, Rachel A K Atkinson, et al.
Acta Neuropathologica Communications|September 27, 2015
C9ORF72 expression and cellular localization over mouse developmentRachel A K Atkinson, Carmen M Fernandez-Martos, Julie D Atkin, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer's diseaseCarmen M Fernandez-Martos, Rachel A K Atkinson, Meng I Chuah, et al.
Acta Neuropathologica Communications|January 6, 2016
Erratum: C9ORF72 expression and cellular localization over mouse developmentRachel A K Atkinson, Carmen M Fernandez-Martos, Julie D Atkin, et al.
The Journal of Comparative Neurology|December 18, 2016
Mid-life environmental enrichment increases synaptic density in CA1 in a mouse model of Aβ-associated pathology and positively influences synaptic and cognitive health in healthy ageingKimberley E Stuart, Anna E King, Carmen M Fernandez-Martos, et al.
Pageof 2